Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 15, 2021 14:14 ET | Source: AMAG Pharmaceuticals, Inc.

COVIS PHARMA GROUP gibt wichtigste Sicherheits- und Wirksamkeitsdaten einer placebokontrollierten Phase-3-Studie zu COVID-19 mit inhalativem Kortikosteroid (Ciclesonid) bekannt

ZUG, Schweiz, April 15, 2021 (GLOBE NEWSWIRE) -- Die Covis Pharma Group (das „Unternehmen“), ein globales spezialisiertes Pharmaunternehmen, das therapeutische Lösungen für Patienten mit...
April 15, 2021 14:14 ET | Source: AMAG Pharmaceuticals, Inc.

COVIS PHARMA GROUP annonce les premières données d'innocuité et d'efficacité d'une étude de phase 3 contrôlée par placebo sur la COVID-19 utilisant du corticostéroïde inhalé (ciclésonide)

ZOUG, Suisse, 15 avr. 2021 (GLOBE NEWSWIRE) -- Covis Pharma Group (la « Société »), société pharmaceutique spécialisée mondiale qui commercialise des solutions thérapeutiques pour les patients...
April 15, 2021 07:00 ET | Source: Covis Pharma Group

COVIS PHARMA GROUP Announces Top-line Safety and Efficacy Data from a Phase 3 Placebo-Controlled COVID-19 Study Using Inhaled Corticosteroid (ciclesonide)

ZUG, Switzerland, April 15, 2021 (GLOBE NEWSWIRE) -- Covis Pharma Group (the “Company”), a global specialty pharmaceutical company that markets therapeutic solutions for patients with...
December 14, 2020 08:47 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Files Submission in Response To the Food And Drug Administration’s Notice of Opportunity for a Hearing and Proposal To Withdraw Approval of Makena® (hydroxyprogesterone caproate injection)

WALTHAM, Mass., Dec. 14, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. has submitted its response to the FDA’s Notice of Opportunity for a Hearing (“NOOH”) regarding the Agency’s proposal to...
October 14, 2020 16:11 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Requests Hearing to Maintain Makena® (Hydroxyprogesterone Caproate Injection) as a Treatment Option for Clinically Indicated Pregnant Patients

WALTHAM, Mass., Oct. 14, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) announced today that it has formally requested a public hearing in response to the U.S. Food and Drug...
October 05, 2020 21:05 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Provides Update on FDA’s Proposal Regarding Makena® (Hydroxyprogesterone Caproate Injection)

The product remains on the marketAMAG has 15 days to respond to the FDAAMAG continues to expect its recently announced tender offer and merger to close in November 2020 WALTHAM, Mass., Oct. 05, 2020...
October 01, 2020 10:45 ET | Source: AMAG Pharmaceuticals, Inc.

Covis Group Announces Agreement to Acquire AMAG Pharmaceuticals

Addition of AMAG’s category leading treatments positions Covis to become a global market leader of therapeutic solutions for life-threatening conditions and chronic illnesses Covis will commence a...
September 09, 2020 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals to Participate in H.C. Wainwright 22nd Annual Global Investment Conference

WALTHAM, Mass., Sept. 09, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that Scott Myers, Chief Executive Officer, and Brian Piekos, Chief Financial Officer,...
August 06, 2020 07:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Corporate Update

Financial guidance reissued to include EBITDA-positive projection for second-half 2020 Strategic shift and momentum build through recent business development activities Brian Piekos promoted to...
July 28, 2020 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals to Host Second Quarter FY 2020 Financial Results Conference Call and Webcast on Thursday, August 6, 2020

WALTHAM, Mass., July 28, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that its second quarter 2020 financial results will be released on Thursday, August 6,...